Minerva Surgical, Inc. (UTRS)

0.0010 0.0000 (0.00%) As of 11:21AM EDT. Market open.

Minerva Surgical, Inc.

4255 Burton Drive
Santa Clara, CA 95054
United States
855 646 7874
https://minervasurgical.com

Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees: 174

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Todd Usen	President, CEO & Director	N/A	N/A	1967
Mr. Greg Simbro	Vice President of Finance	N/A	N/A	N/A
Mr. Erik Reese	Vice President of Sales	N/A	N/A	N/A
Ms. Wendy Bowman	Vice President of Human Resources	N/A	N/A	N/A
Dr. Evgueni V. Skalnyi M.D.	Chief Medical Officer	365.25k	N/A	1966
Ms. Joanne Long	Vice President of Corporate Controller	N/A	N/A	N/A

Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company provides Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.

Corporate Governance

Minerva Surgical, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.